NO931917L - Farmas!ytiske forbindelser - Google Patents

Farmas!ytiske forbindelser

Info

Publication number: NO931917L
Authority: NO; Norway
Prior art keywords: alkyl; pharmaceutical compounds; optionally substituted; cycloalkyl; alkyl groups
Prior art date: 1992-05-29

Application number

NO931917A

Other languages

English (en)

Other versions

NO931917D0 (no

NO305125B1 (no

Inventor

John Fairhurst

Terrence Michael Hotten

David Edward Tupper

Original Assignee

Lilly Industries Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-05-29

Filing date

1993-05-26

Publication date

1993-11-30

1992-05-29 Priority claimed from GB929211379A external-priority patent/GB9211379D0/en

1993-04-30 Priority claimed from GB939309025A external-priority patent/GB9309025D0/en

1993-05-26 Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd

1993-05-26 Publication of NO931917D0 publication Critical patent/NO931917D0/no

1993-11-30 Publication of NO931917L publication Critical patent/NO931917L/no

1999-04-06 Publication of NO305125B1 publication Critical patent/NO305125B1/no

Links

150000001875 compounds Chemical class 0.000 title abstract 2
125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 4
125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
125000006374 C2-C10 alkenyl group Chemical group 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
125000000304 alkynyl group Chemical group 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
125000001475 halogen functional group Chemical group 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Addiction (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO931917A 1992-05-29 1993-05-26 Farmas°ytiske forbindelser NO305125B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB929211379A GB9211379D0 (en)	1992-05-29	1992-05-29	Pharmaceutical compounds
GB939309025A GB9309025D0 (en)	1993-04-30	1993-04-30	Pharmaceutical compounds

Publications (3)

Publication Number	Publication Date
NO931917D0 NO931917D0 (no)	1993-05-26
NO931917L true NO931917L (no)	1993-11-30
NO305125B1 NO305125B1 (no)	1999-04-06

Family

ID=26300951

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO931917A NO305125B1 (no)	1992-05-29	1993-05-26	Farmas°ytiske forbindelser

Country Status (21)

Country	Link
EP (1)	EP0582368B1 (no)
JP (1)	JP3219541B2 (no)
CN (1)	CN1043994C (no)
AT (1)	ATE198891T1 (no)
AU (1)	AU668159B2 (no)
CA (1)	CA2097016A1 (no)
CZ (1)	CZ282783B6 (no)
DE (1)	DE69329887T2 (no)
DK (1)	DK0582368T3 (no)
ES (1)	ES2153373T3 (no)
FI (1)	FI101538B (no)
GR (1)	GR3035587T3 (no)
HU (1)	HU218278B (no)
IL (1)	IL105827A (no)
MX (1)	MX9303124A (no)
MY (1)	MY109943A (no)
NO (1)	NO305125B1 (no)
NZ (1)	NZ247703A (no)
PT (1)	PT582368E (no)
RU (1)	RU2125574C1 (no)
TW (1)	TW268005B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5457101A (en) *	1994-06-03	1995-10-10	Eli Lilly And Company	Thieno[1,5]benzoidiazepine use
US5574028A (en) *	1994-10-31	1996-11-12	Eli Lilly And Company	Method for treating anxiety
CR5278A (es) *	1995-03-24	1996-07-04	Lilly Co Eli	Formulacion oral de 2-metil-tieno-benzodiacepina
EG24221A (en) *	1995-03-24	2008-11-10	Lilly Co Eli	Process for preparing olanzapine
EG23659A (en) *	1995-03-24	2007-03-26	Lilly Co Eli	Process and crystal forms of methyl-thieno-benzodiazepine
US5891461A (en) *	1995-09-14	1999-04-06	Cygnus, Inc.	Transdermal administration of olanzapine
EP0932407A4 (en) *	1996-03-25	2002-04-24	Lilly Co Eli	TECHNIQUE FOR TREATING MIGRAINE PAIN
CN1494907A (zh) *	1996-03-25	2004-05-12		治疗疼痛的药物组合物
IL126064A0 (en) *	1996-03-25	1999-05-09	Lilly Co Eli	Method for treating pain
TR199900639T2 (xx)	1996-09-23	1999-06-21	Eli Lilly And Company	Olanzapin dihidrat D.
ZA978515B (en) *	1996-09-23	1999-03-23	Lilly Co Eli	Intermediates and process for preparing olanzapine
CA2266448A1 (en) *	1996-09-24	1998-04-02	Eli Lilly And Company	Coated particle formulation
RU2185383C1 (ru) *	2001-05-22	2002-07-20	Институт молекулярной генетики РАН	ВЫСОКОМЕЧЕННЫЙ ТРИТИЕМ 2-МЕТИЛ-4-(4-МЕТИЛ-1-ПИПЕРАЗИНИЛ)-10Н-ТИЕНО[2,3-b][1,5]БЕНЗОДИАЗЕПИН
CN110054694B (zh)	2012-08-21	2024-02-20	詹森药业有限公司	阿立哌唑半抗原的抗体及其用途
CA2882454C (en) *	2012-08-21	2020-08-11	Matthew Garrett DONAHUE	Haptens of olanzapine
CA2882489A1 (en)	2012-08-21	2014-02-27	Ortho-Clinical Diagnostics, Inc.	Antibodies to paliperidone haptens and use thereof
PT3462173T (pt)	2012-08-21	2021-04-28	Janssen Pharmaceutica Nv	Anticorpos contra risperidona e utilização dos mesmos
EP2888263B1 (en)	2012-08-21	2018-05-09	Janssen Pharmaceutica NV	Haptens of risperidone and paliperidone
US20140057303A1 (en)	2012-08-21	2014-02-27	Janssen Pharmaceutica Nv	Antibodies to Olanzapine Haptens and Use Thereof
AU2013305879B2 (en)	2012-08-21	2017-10-12	Saladax Biomedical Inc.	Antibodies to aripiprazole and use thereof
PL3321254T3 (pl)	2012-08-21	2021-01-11	Janssen Pharmaceutica Nv	Hapteny arypiprazolu i ich zastosowanie w testach immunologicznych
AU2013305930B2 (en)	2012-08-21	2017-08-24	Saladax Biomedical Inc.	Haptens of paliperidone
HK1211958A1 (en)	2012-08-21	2016-06-03	Ortho-Clinical Diagnostics, Inc.	Antibodies to paliperidone and use thereof
WO2014031645A1 (en)	2012-08-21	2014-02-27	Ortho-Clinical Diagnostics, Inc	Antibodies to risperidone haptens and use thereof
JP6216926B2 (ja)	2012-08-21	2017-10-25	ヤンセンファーマシューティカエヌ．ベー．	オランザピンに対する抗体及びその使用
EP3305784B1 (en)	2012-08-21	2020-08-12	Janssen Pharmaceutica NV	Haptens of quetiapine for use in immunoassays
PL3333195T3 (pl)	2012-08-21	2021-02-22	Janssen Pharmaceutica Nv	Przeciwciała względem kwetiapiny i ich zastosowania
PL3663317T3 (pl)	2012-08-21	2023-06-05	Janssen Pharmaceutica Nv	Przeciwciała skierowane przeciwko haptenom kwetiapinowym i ich zastosowanie
WO2017106508A1 (en)	2015-12-17	2017-06-22	Janssen Pharmaceutica Nv	Antibodies to quetiapine and use thereof
AU2016372069A1 (en)	2015-12-17	2018-06-07	Saladax Biomedical Inc.	Antibodies to risperidone and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3962248A (en) *	1972-04-04	1976-06-08	Sandoz, Inc.	Process for making 11-piperazino-diazepines, oxazepines, thiazepines and azepines
CH569731A5 (no) *	1972-04-04	1975-11-28	Wander Ag Dr A
SU629879A3 (ru) *	1974-11-26	1978-10-25	Лилли Индастриз Лимитед, (Фирма)	Способ получени тиено(1,5) бензодиазепинов или их солей
US4061752A (en) *	1975-08-06	1977-12-06	Sandoz Ltd.	6-Piperazino-11-methylene-dibenzazepines[b,e]
DE2641378A1 (de) *	1975-09-24	1977-04-07	Sandoz Ag	Neue organische verbindungen, ihre verwendung und herstellung
CH624682A5 (no) *	1976-11-10	1981-08-14	Sandoz Ag
US4761411A (en) *	1983-05-18	1988-08-02	Hoechst-Roussel Pharmaceuticals Inc.	Dihydrobenzopyrrolobenzodiazepines useful for treating pyschoses
GB9009229D0 (en) *	1990-04-25	1990-06-20	Lilly Industries Ltd	Pharmaceutical compounds

1993
- 1993-05-26 AU AU39807/93A patent/AU668159B2/en not_active Ceased
- 1993-05-26 EP EP93304102A patent/EP0582368B1/en not_active Expired - Lifetime
- 1993-05-26 NZ NZ247703A patent/NZ247703A/en unknown
- 1993-05-26 DK DK93304102T patent/DK0582368T3/da active
- 1993-05-26 PT PT93304102T patent/PT582368E/pt unknown
- 1993-05-26 AT AT93304102T patent/ATE198891T1/de not_active IP Right Cessation
- 1993-05-26 ES ES93304102T patent/ES2153373T3/es not_active Expired - Lifetime
- 1993-05-26 NO NO931917A patent/NO305125B1/no not_active IP Right Cessation
- 1993-05-26 CA CA002097016A patent/CA2097016A1/en not_active Abandoned
- 1993-05-26 DE DE69329887T patent/DE69329887T2/de not_active Expired - Fee Related
- 1993-05-26 TW TW082104161A patent/TW268005B/zh active
- 1993-05-27 MX MX9303124A patent/MX9303124A/es not_active IP Right Cessation
- 1993-05-28 CZ CZ931024A patent/CZ282783B6/cs not_active IP Right Cessation
- 1993-05-28 HU HU9301579A patent/HU218278B/hu not_active IP Right Cessation
- 1993-05-28 IL IL10582793A patent/IL105827A/xx not_active IP Right Cessation
- 1993-05-28 CN CN93108212A patent/CN1043994C/zh not_active Expired - Fee Related
- 1993-05-28 MY MYPI93001036A patent/MY109943A/en unknown
- 1993-05-28 RU RU93005057A patent/RU2125574C1/ru active
- 1993-05-28 JP JP12642993A patent/JP3219541B2/ja not_active Expired - Fee Related
- 1993-05-28 FI FI932445A patent/FI101538B/fi active
2001
- 2001-03-15 GR GR20010400431T patent/GR3035587T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
CZ282783B6 (cs)	1997-10-15
IL105827A (en)	1997-02-18
JP3219541B2 (ja)	2001-10-15
CA2097016A1 (en)	1993-11-30
CN1085903A (zh)	1994-04-27
MY109943A (en)	1997-10-31
ES2153373T3 (es)	2001-03-01
FI932445L (fi)	1993-11-30
DK0582368T3 (da)	2001-02-05
IL105827A0 (en)	1993-09-22
RU2125574C1 (ru)	1999-01-27
NZ247703A (en)	1995-07-26
CZ102493A3 (en)	1993-12-15
EP0582368A1 (en)	1994-02-09
AU668159B2 (en)	1996-04-26
CN1043994C (zh)	1999-07-07
FI101538B1 (fi)	1998-07-15
AU3980793A (en)	1993-12-02
HU9301579D0 (en)	1993-09-28
ATE198891T1 (de)	2001-02-15
NO931917D0 (no)	1993-05-26
DE69329887D1 (de)	2001-03-01
FI101538B (fi)	1998-07-15
FI932445A0 (fi)	1993-05-28
JPH0687862A (ja)	1994-03-29
GR3035587T3 (en)	2001-06-29
PT582368E (pt)	2001-05-31
HUT66180A (en)	1994-09-28
MX9303124A (es)	1993-11-01
EP0582368B1 (en)	2001-01-24
TW268005B (no)	1996-01-11
DE69329887T2 (de)	2001-05-23
NO305125B1 (no)	1999-04-06
HU218278B (en)	2000-07-28

Legal Events

Date	Code	Title	Description
2002-12-30	MM1K	Lapsed by not paying the annual fees	Free format text: LAPSED IN NOVEMBER 2002

Publication	Publication Date	Title
NO931917D0 (no)	1993-05-26	Farmasoeytiske forbindelser
KR930703355A (ko)	1993-11-29	항생물질 ge2270 인자의 아미드
DK0674513T3 (da)	1997-03-17	Retroviral protease-inhiberende forbindelser
DE69231661D1 (de)	2001-03-01	Antifungizide trisubstituierte tetrahydrofurane
PH25859A (en)	1991-12-02	Composition for treatment of ischemic disorder
FI920023A0 (fi)	1992-01-03	Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
IL110151A0 (en)	1994-10-07	Amide and urea derivatives and pharmaceutical compositions containing the same
SE9100920D0 (sv)	1991-03-27	New active compounds
SE8404065D0 (sv)	1984-08-10	Novel biologically active compounds
ATE117989T1 (de)	1995-02-15	Prostaglandinanaloge enthaltende lipidemulsion.
EP0103320A3 (en)	1984-09-05	Acetylsalicylic acid thioesters, a process for their preparation and pharmaceutical compositions containing them
DK0424194T3 (da)	1994-10-03	Benzanilider
ATE145911T1 (de)	1996-12-15	Inositol-phosphat-analog als kalzium- antagonistische substanz
TW275629B (no)	1996-05-11
GB8823040D0 (en)	1988-11-09	Organic compounds & their use as pharmaceuticals
DE3867494D1 (de)	1992-02-20	Fluor enthaltende vitamin-d2-derivate.
ES2037825T3 (es)	1993-07-01	Uso farmaceutico de tioeteres aromaticos.
GB8823042D0 (en)	1988-11-09	Organic compounds & their use as pharmaceuticals
GB9617822D0 (en)	1996-10-09	Pharmaceutical compounds